189 related articles for article (PubMed ID: 2883876)
1. Clinical significance of beta 1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drug.
Frishman WH
Am J Cardiol; 1987 May; 59(13):33F-37F. PubMed ID: 2883876
[TBL] [Abstract][Full Text] [Related]
2. Impact of beta 1 selectivity and intrinsic sympathomimetic activity on potential unwanted noncardiovascular effects of beta blockers.
Kendall MJ
Am J Cardiol; 1987 May; 59(13):44F-47F. PubMed ID: 2883878
[TBL] [Abstract][Full Text] [Related]
3. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
4. The additional properties of beta adrenoceptor blocking drugs.
Prichard BN; Tomlinson B
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic sympathomimetic activity: clinical fact or fiction?
Taylor SH
Am J Cardiol; 1983 Nov; 52(9):16D-26D. PubMed ID: 6139009
[TBL] [Abstract][Full Text] [Related]
6. Potential benefit of combination therapy with diuretics and beta blockers having intrinsic sympathomimetic activity.
Weinberger MH
Eur Heart J; 1990 Jun; 11(6):560-5. PubMed ID: 1972064
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic aspects of intrinsic sympathomimetic activity in beta-blocking drugs.
Prichard BN
Am J Cardiol; 1987 May; 59(13):13F-17F. PubMed ID: 2883871
[TBL] [Abstract][Full Text] [Related]
8. Relevance of intrinsic sympathomimetic activity for beta blockers.
Jaillon P
Am J Cardiol; 1990 Sep; 66(9):21C-23C. PubMed ID: 1977302
[TBL] [Abstract][Full Text] [Related]
9. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
[TBL] [Abstract][Full Text] [Related]
10. Role of cardioselectivity and intrinsic sympathomimetic activity in beta-blocking drugs in cardiovascular disease.
Taylor SH
Am J Cardiol; 1987 May; 59(13):18F-20F. PubMed ID: 2883872
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
Lehtonen A
J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta blockers on blood lipid profile.
Lehtonen A
Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
[TBL] [Abstract][Full Text] [Related]
13. The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids.
van Brummelen P
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S51-5. PubMed ID: 6188920
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
Man in 't Veld AJ; Schalekamp MA
Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
Kostis JB; DeFelice EA; Frishman W; Hosler M; Krieger SK; Aglitz N; Kuo PT
Angiology; 1981 Nov; 32(11):780-7. PubMed ID: 6119937
[TBL] [Abstract][Full Text] [Related]
16. Beta blockers in hypertension.
Thadani U
Am J Cardiol; 1983 Nov; 52(9):10D-15D. PubMed ID: 6139008
[TBL] [Abstract][Full Text] [Related]
17. Beta blockers with intrinsic sympathomimetic activity.
White WB
Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.
Cocco G; Burkart F; Chu D; Follath F
Eur J Clin Pharmacol; 1978 Mar; 13(1):1-4. PubMed ID: 25186
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic properties of beta-blocking drugs influencing choice in treatment of systemic hypertension.
Harrison DC
Am J Cardiol; 1987 Sep; 60(9):13E-16E. PubMed ID: 2889349
[TBL] [Abstract][Full Text] [Related]
20. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
